Treatment outcome after radiochemotherapy in anal cancer patients staged with 18F-FDG-PET-CT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment outcome after radiochemotherapy in anal cancer patients staged with 18F-FDG-PET-CT

Published:2020-09 Issue: Volume:24 Page:83-87
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Braun L.H.,Reinert C.P.,Zips D.,Nikolaou K.,Pfannenberg C.,Gani C.

Funder

Eberhard Karls Universität Tübingen

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference37 articles.

1. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base;Bilimoria;Dis Colon Rectum,2009

2. Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973–2000;Johnson;Cancer,2004

3. Squamous-cell carcinoma of the anus: Progress in radiotherapy treatment;Glynne-Jones;Nat Rev Clin Oncol,2016

4. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal;Ajani;JAMA,2008

5. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastro;Bartelink;J Clin Oncol,1997

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma;European Radiology;2023-11-04

2. [18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis;European Journal of Nuclear Medicine and Molecular Imaging;2023-08-18

3. Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma;Strahlentherapie und Onkologie;2023-03-02

4. Body Composition as a Predictor of the Survival in Anal Cancer;Cancers;2022-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3